Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism.
about
Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effectsBursts and oscillations as independent properties of neural activity in the parkinsonian globus pallidus internusNocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis.Basal ganglia contributions to motor control: a vigorous tutorThe external globus pallidus: progress and perspectivesThe nature of tremor circuits in parkinsonian and essential tremorAlterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activityFunctional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats.Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease.The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian ratsCorrelation transfer from basal ganglia to thalamus in Parkinson's diseaseInversion of dopamine responses in striatal medium spiny neurons and involuntary movements.State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats.The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate.Mechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption?Pallidostriatal Projections Promote β Oscillations in a Dopamine-Depleted Biophysical Network ModelRight external globus pallidus changes are associated with altered causal awareness in youth with depression.Computational Model of Recurrent Subthalamo-Pallidal Circuit for Generation of Parkinsonian Oscillations.Review: electrophysiology of basal ganglia and cortex in models of Parkinson disease.The highs and lows of beta activity in cortico-basal ganglia loops.Reassessing models of basal ganglia function and dysfunction.Electrical stimulation of the dorsal columns of the spinal cord for Parkinson's disease.Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.Use of 2-aminoprop-1-ene-1,1,3-tricarbonitrile for the synthesis of tetrahydronaphthalene, hexahydroisoquinoline and hexahydrocinnoline derivatives with potential antitumor activities.Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.Subthalamic nucleus gamma activity increases not only during movement but also during movement inhibition.Neighboring Pallidal Neurons Do Not Exhibit more Synchronous Oscillations than Remote Ones in the MPTP Primate Model of Parkinson's Disease.Balance of increases and decreases in firing rate of the spontaneous activity of basal ganglia high-frequency discharge neurons.Bicuculline-induced chorea manifests in focal rather than globalized abnormalities in the activation of the external and internal globus pallidus.Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia.Metabotropic glutamate receptor II in the brains of Parkinsonian patients.The reaction of beta-amino-alpha,gamma-dicyanocrotononitrile with acetophenone: synthesis of pyridine, pyridazine and thiophene derivatives with antimicrobial activities.Cortical effects of subthalamic stimulation correlate with behavioral recovery from dopamine antagonist induced akinesia.A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.Irregular activity arises as a natural consequence of synaptic inhibition.
P2860
Q28271277-CAF8C2A4-8016-43DF-99D7-8451241FF062Q28748326-AF41AA1E-5D79-4B0D-A9E5-D0FCE6B05ED4Q34311226-8F244D05-5DF5-46F4-AAD2-63F79F0A8C3FQ34511125-F8A43B52-2C61-4CB2-A636-BDA47D67705DQ34512150-68D24BCE-F438-4157-8472-95208F3606BDQ34555912-6D991D8A-C387-47ED-9D15-D22E0224CEF4Q35053448-DC7CA9D0-7898-4168-84F4-90CCDD25E9C2Q35053921-B9BEBAFB-4940-475A-9F2D-5FAEEC46EB04Q35053960-873FACEB-D2EA-4197-B300-2CB7488D155FQ35056590-C0456D51-3EE2-48AC-B35D-BB7070E435FAQ35540050-C2737ACA-733D-43C7-9026-0C012E29A678Q35759812-6A393587-A28C-4AED-B429-87D78853B6F2Q35932567-1290DE25-A67D-4924-99CE-41453BE38711Q36178312-7DD69D73-966C-4728-A6E2-CAFBBA800B3AQ36241835-41ED1A24-B125-45C6-B93F-2815F1AA948AQ36912305-DF0E030F-E79A-47A3-86DD-B9B47C1AE98BQ36914321-58A9B085-6765-4B79-911A-9F3AFDC56367Q37058630-1534E649-36F0-4C6A-A57A-F489D82A5246Q37712531-2E85B0F9-43F9-4DE2-8617-600A5CA4EC41Q38129241-B79D666D-CF89-4C2D-82EA-DE2CE36BBC5EQ38217078-4DD5EB82-1D3B-48AF-8D58-0A2BD0980C9BQ38230498-8625F5EE-B8AC-4BB9-B398-730037166EACQ39302042-8B82990A-11EC-4ECA-BA9E-4B987F563408Q39364667-01E9FF65-CDAE-403C-83D2-3B1E8DC70828Q39575810-4611B242-B748-4AA5-AD6E-2F3F3A3589A9Q40261126-84E11ABC-267B-46DB-BDD8-C11E1E5440C1Q41121794-C60DF428-10DF-44E0-B76C-EF623735A0BAQ42180867-5757FF6D-58F9-4AB0-8A75-9EAC4F67211CQ42442871-8997F978-4161-4D5F-A75F-D81BED2FA2DAQ42473597-6A9D7396-FE2D-4010-888B-5E4E01D00C17Q42496687-A39BDB72-48E8-471C-9A0D-2466AFC05A09Q46087825-B203689F-1040-42E6-BA43-021BE2AD95ABQ46185854-B32A108C-48B9-41BC-89CF-CBB0C7374584Q46372624-806DA0A3-282D-442C-BBF7-15B5DD43DB38Q48915741-719E4EDA-D7EC-4CE8-B427-8AF59D9747F2Q51126466-FA449806-99FF-4F2B-AABD-34AFB814EE1F
P2860
Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dopamine replacement therapy d ...... primate model of Parkinsonism.
@en
Dopamine replacement therapy d ...... primate model of Parkinsonism.
@nl
type
label
Dopamine replacement therapy d ...... primate model of Parkinsonism.
@en
Dopamine replacement therapy d ...... primate model of Parkinsonism.
@nl
prefLabel
Dopamine replacement therapy d ...... primate model of Parkinsonism.
@en
Dopamine replacement therapy d ...... primate model of Parkinsonism.
@nl
P2093
P1476
Dopamine replacement therapy d ...... primate model of Parkinsonism
@en
P2093
Gali Heimer
Hagai Bergman
Izhar Bar-Gad
Michal Rivlin-Etzion
Suzanne N Haber
P304
P356
10.1523/JNEUROSCI.5140-05.2006
P407
P577
2006-08-01T00:00:00Z